Baldwidx, every 6-12 months I need to say this. While I agree...

Baldwidx, every 6-12 months I need to say this.
While I agree that should all the studies be positive in P2 AND P3 then a price scenario as you have stated is definitely possible, we are NOT in that position and any takeover price will be ruled by the current price at the time. The average takeover premium on the Australian market is 30%. In the case of the US Market the premiums for the takeover of orphan drug companies ranges from 50-125% with 75-100% being the average. There are a few outliers to the high side and a few to the low side. So, the current share price is the dictator of the ultimate takeover price. If we are trading at $20 then I would hope for something between $35 & $40. If it’s trading at $30 then maybe $50-60. For your $93 to come to fruition then we would have to be trading somewhere north of $45.
Let’s also hope (as others here have mentioned) we don’t get a low ball offer at the Australian market 30% premium. I’m sure our directors would dismiss this out of hand however nothing is guaranteed.
We are currently trading at $15, if love to see this at $20+ post P2 PMS results so that a $40 takeover is on the cards.
If we don’t get an offer until mid 24 and the P2’s are all successful then we could be in the high $20’s or maybe $30 which, to me, would be a great base price from which to receive a T/O offer.